BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE: EW ) with a Buy and raises the price target from $100 to $110.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.